Abbott reports positive FreeDM2 study results for CGM

​Abbott has announced results from the FreeDM2 RCT, indicating that better glucose outcomes were observed in individuals using the FreeStyle Libre CGM technology for type 2 diabetes.

The post Abbott reports positive FreeDM2 study results for CGM appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Bruker unveils MyGenius PRO diagnostics system
Agenus announces Phase II results from gastroesophageal cancer therapy
MSD secures EC approval for Enflonsia to prevent infant RSV infection
Philips secures FDA clearance for Verida spectral CT system
First patient receives JANX014 dose in Janux’s trial for mCRPC

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us